Edwards Lifesciences (EW) Target Lifted to $94 at Jefferies Post Q1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 7c, Updates Guidance
April 24, 2014 4:50 PM EDTEdwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.76, $0.07 better than the analyst estimate of $0.69. Revenue for the quarter came in at $522.4 million versus the consensus estimate of $523.1 million.
Edwards Lifesciences Corp. sees FY2014 EPS of $3.10, versus the consensus of $3.06. Edwards Lifesciences Corp.... More
